In the PPE‐induced emphysema model, an 8‐week treatment with ABT‐263 resulted in a partial decrease in p19ARF‐expressing cell numbers, with a concomitant reduction in INK4a expression in lung tissues. Here, CDKN2A is linked to pulmonary emphysema.